KCCQ-23

Biomarker1 paper1 finding

Humans1

Interventions

1

Dapagliflozin

upin humans1Very low certainty

1 study

Dapagliflozin improves KCCQ-23 in humans.
Humansin HFrEF patients12 monthsn = 257
Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results · Clinical cardiology · 1 Sep 2026

Dapagliflozin →

Latest

2

Frontiers in Cardiovascular MedicineHumans23 Sep

Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom

Clinical CardiologyHumans6 Sep

Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results